FEROX STRATEGIES

Lobbying for ALEXION PHARMACEUTICALS, INC. · Rare Disease Pharmaceutical company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $60,000.00 income · posted Oct 20, 2025

Bills named in this filing 1

Lobbying activity 1

Health Issues

Issues related to rare disease pharmaceuticals, Orphan Cures H.R. 946, and Pediatric Priority Review Voucher.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.